ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2022Yacktman Asset ManagementSell-17,937386,577$189,894
Q1 2022Sound Shore ManagementSell-59,404159,049$78,128
Q1 2022Sequoia Financial AdvisorsBuy7683,420$1,679
Q1 2022Viking Global InvestorsSell-381,510140,895$69,210
Q1 2022Brave Warrior AdvisorsSell-12,5361,353,249$664,743
Q1 2022Sequoia FundSell-12,6121,757,428$863,284
Q1 2022First Eagle U.S. ValueBuy11,1292,028,985$996,678
Q1 2022Hancock Classic ValueBuy260190,746$93,698
Q4 2021Eagle Capital ManagementSell-88,4552,458,440$1,139,585
Q4 2021Yacktman Asset ManagementBuy2,206404,514$187,508
Q4 2021Sound Shore ManagementSell-23,876218,453$101,262
Q4 2021Sequoia Financial AdvisorsBuy1592,652$1,229
Q4 2021Renaissance Technologies LLCBuy179,300190,373$88,246
Q4 2021Brave Warrior AdvisorsSell-5,4771,365,785$633,096
Q4 2021Sequoia FundSell-51,3731,770,040$820,484
Q4 2021First Eagle U.S. ValueSell-28,5842,017,856$935,357
Q4 2021Hancock Classic ValueSell-1,454190,486$88,298
Q3 2021Eagle Capital ManagementSell-78,9132,546,895$949,482
Q3 2021Yacktman Asset ManagementSell-3,046402,308$149,980
Q3 2021Sound Shore ManagementBuy26,238242,329$90,340
Q3 2021Renaissance Technologies LLCSell-226,20011,073$4,128
Q3 2021Vulcan Value PartnersSell-11,7021,168,878$435,757
Q3 2021Brave Warrior AdvisorsBuy225,8461,371,262$511,206
Q3 2021Sequoia FundSell-22,5881,821,413$679,023
Q3 2021First Eagle U.S. ValueBuy92,0572,046,440$762,913
Q3 2021Hancock Classic ValueBuy189,502191,940$71,555
Q2 2021Eagle Capital ManagementBuy404,8112,625,808$1,002,533
Q2 2021Yacktman Asset ManagementSell-1,285405,354$154,764
Q2 2021Sound Shore ManagementSell-6,095216,091$82,504
Q2 2021Sequoia Financial AdvisorsBuy8152,493$952

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.